Global Electromechanical Ventricular Assist Device Market Growth 2025-2031

The global Electromechanical Ventricular Assist Device market size is predicted to grow from US$ 2885 million in 2025 to US$ 5832 million in 2031; it is expected to grow at a CAGR of 12.4% from 2025 to 2031.

A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.

United States market for Electromechanical Ventricular Assist Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Electromechanical Ventricular Assist Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Electromechanical Ventricular Assist Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Electromechanical Ventricular Assist Device players cover AbioMed, Abbott (Thoratec), Medtronic (HeartWare), Berlin Heart, Jarvik Heart, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Electromechanical Ventricular Assist Device Industry Forecast” looks at past sales and reviews total world Electromechanical Ventricular Assist Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Electromechanical Ventricular Assist Device sales for 2025 through 2031. With Electromechanical Ventricular Assist Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Electromechanical Ventricular Assist Device industry.

This Insight Report provides a comprehensive analysis of the global Electromechanical Ventricular Assist Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Electromechanical Ventricular Assist Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Electromechanical Ventricular Assist Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Electromechanical Ventricular Assist Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Electromechanical Ventricular Assist Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Electromechanical Ventricular Assist Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

LVADs

RVADs

Segmentation by Application:

Bridge-to-transplant (BTT)

Destination Therapy (DT)

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

AbioMed

Abbott (Thoratec)

Medtronic (HeartWare)

Berlin Heart

Jarvik Heart

Sun Medical Technology Research

ReliantHeart

Key Questions Addressed in this Report

What is the 10-year outlook for the global Electromechanical Ventricular Assist Device market?

What factors are driving Electromechanical Ventricular Assist Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Electromechanical Ventricular Assist Device market opportunities vary by end market size?

How does Electromechanical Ventricular Assist Device break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.